In response to an increase in the amount of reported injuries and lawsuits resulting from surgical mesh implants, Johnson & Johnson has decided to stop selling the product used to treat women’s health problems. The company expressed its desire to do so in a letter sent to judges in New Jersey and West Virginia who are overseeing patient lawsuits against the company. The plastic mesh is used to strengthen the pelvic wall in cases of pelvic organ prolapse, in which the bladder or other reproductive organs slip down into the vagina. However, J&J irresponsibly claims the mesh products are safe and that it does not plan on recalling them, as their decision to discontinue such products is based on “commercial viability in light of changing market dynamics.” This is in contrast to a report issued last year by the Food and Drug Administration about the side effects of vaginal mesh, which provided evidence that the implants were associated with higher rates of pain, bleeding, and infection. Moreover, the FDA stated that 10 percent of women experienced erosion or exposure of the mesh within 12 of having it implanted, and that some even required two or three surgeries to have it removed. Consumer safety advocates have hailed the announcement as a victory. J&J’s failure to adequately warn of the risks of vaginal mesh has led to vaginal mesh lawsuits being filed across the country.